1. Home
  2. FC vs CABA Comparison

FC vs CABA Comparison

Compare FC & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Covey Company

FC

Franklin Covey Company

HOLD

Current Price

$16.83

Market Cap

193.2M

ML Signal

HOLD

Logo Cabaletta Bio Inc.

CABA

Cabaletta Bio Inc.

HOLD

Current Price

$2.19

Market Cap

210.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FC
CABA
Founded
1983
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
210.8M
IPO Year
1992
2019

Fundamental Metrics

Financial Performance
Metric
FC
CABA
Price
$16.83
$2.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$24.50
$14.57
AVG Volume (30 Days)
124.2K
1.9M
Earning Date
01-07-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$267,067,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$4.35
N/A
P/E Ratio
$70.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.04
$0.99
52 Week High
$39.22
$3.67

Technical Indicators

Market Signals
Indicator
FC
CABA
Relative Strength Index (RSI) 53.77 42.63
Support Level $16.63 $2.12
Resistance Level $17.48 $2.49
Average True Range (ATR) 0.47 0.12
MACD 0.02 -0.02
Stochastic Oscillator 51.70 21.79

Price Performance

Historical Comparison
FC
CABA

About FC Franklin Covey Company

Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: